Health and Human Services Secretary Robert F. Kennedy Jr. appears before the Senate Finance Committee at the Dirksen Senate Office Building on Sept. 4, 2025 in Washington, D.C. (Photo by Andrew Harnik/Getty Images)

WASHINGTON — Health and Human Services Secretary Robert F. Kennedy Jr.  vehemently defended his actions on vaccines and other public health issues under questioning by both Republican and Democratic senators during a contentious hearing Thursday.

Kennedy, confirmed on a mostly party-line vote earlier this year, repeatedly justified firing everyone on an influential vaccine advisory panel, as well as the president’s decision to remove a Centers for Disease Control and Prevention director who’d served for less than a month after confirmation by the Senate.

“In your confirmation hearings, you promised to uphold the highest standards for vaccines. Since then, I’ve grown deeply concerned,” said Senate Majority Whip John Barrasso, R-Wyo. “The public has seen measles outbreaks. Leadership of the National Institutes of Health questioning the use of mRNA vaccines. The recently confirmed director of the Centers for Disease Control and Prevention fired. Americans don’t know who to rely on.”

Video courtesy of C-SPAN.

Barrasso, an orthopedic surgeon, sought to reinforce support for vaccines to Kennedy during the Senate Finance Committee hearing, saying they “are estimated to have saved 154 million lives worldwide.”

Louisiana Republican Sen. Bill Cassidy, a physician who received several concessions from Kennedy in exchange for voting to confirm him as HHS secretary, raised numerous questions about Kennedy’s behavior. Cassidy is the chairman of the Health, Education, Labor and Pensions Committee.

Cassidy appeared to box in Kennedy on the COVID-19 vaccine by saying President Donald Trump should receive the Nobel Prize for Operation Warp Speed, which led to the development of the shot during his first term. 

Kennedy agreed Trump should “absolutely” get the prize, leading Cassidy to question why he’d taken actions as HHS secretary to erode trust and eliminate funding for vaccine development activities. 

“It surprises me that you think so highly of Operation Warp Speed when, as an attorney, you attempted to restrict access,” Cassidy said. “It also surprises me because you’ve canceled, or HHS did, but apparently under your direction, $500 million in contracts using the mRNA vaccine platform that was critical to Operation Warp Speed.”

Cassidy said the cancellation represents not only “an incredible waste of money but it also seems like a commentary upon what the president did in Operation Warp Speed, which is to create a platform by which to create vaccines.”

Cassidy also questioned Kennedy’s actions eliminating everyone on the CDC’s Advisory Committee on Immunization Practices and replacing them with his own choices. 

“If we put people who are paid witnesses for people suing vaccines, that actually seems like a conflict of interest,” Cassidy said. 

Kennedy disagreed, testifying that “it may be a bias. And that bias, if disclosed, is okay.”

Tillis asks RFK Jr. to respond in writing

North Carolina Republican Sen. Thom Tillis asked Kennedy a series of questions but said he wanted the secretary to submit his answers in writing in order to clarify several of his positions. 

“Some of your statements seem to contradict what you said in the prior hearing,” Tillis said. “You said you’re going to empower the scientists at HHS to do their job. I’d just like to see evidence where you’ve done that, and I’m sure that you will have some.”

Tillis said he wanted Kennedy to respond to reports that he’s gone back on his commitments to senators to not do anything “that makes it difficult or discourages people from taking vaccines” and that Kennedy would not “impose my belief over any of yours.”

“That, again, seems to be contradictory to the firing of the CDC director, the canceling of mRNA research contracts, firing advisory board members, attempting to stall NIH funding, eliminating funding for I think a half a billion dollars for further mRNA research,” he said, referring to the National Institutes of Health. 

Tillis said he was having difficulty understanding why former CDC Director Susan Monarez, whom Trump nominated in March and the Senate voted to confirm in late July, had been fired so quickly. 

“I don’t see how you go … from a public health expert with unimpeachable scientific credentials, a long-time champion of MAHA values, caring and compassionate and brilliant microbiologist — and four weeks later, fire her,” Tillis said. 

CDC shooting, Monarez firing probed

Georgia Democratic Sen. Raphael Warnock questioned Kennedy at length over the firing of Monarez as well as a shooting at the Atlanta-based agency this summer. 

Kennedy testified that he doesn’t believe he criticized Monarez during a meeting in late August over her comments following the CDC shooting that “misinformation can be dangerous.”

During that meeting, Kennedy said he did demand that Monarez fire career CDC scientists but testified he didn’t tell her to accept the recommendations of the vaccine advisory panel without further review.

“What I asked her about is, she had made a statement that she was going to not sign on and I wanted clarification about that,” Kennedy said. “I told her I didn’t want her to have a role if she’s not going to sign onto it.”

Monarez wrote in an op-ed published in the Wall Street Journal just hours before the hearing began that during the meeting with Kennedy she “was told to preapprove the recommendations of a vaccine advisory panel newly filled with people who have publicly expressed antivaccine rhetoric.”

“That panel’s next meeting is scheduled for Sept. 18-19,” Monarez wrote. “It is imperative that the panel’s recommendations aren’t rubber-stamped but instead are rigorously and scientifically reviewed before being accepted or rejected.”

Warnock asked Kennedy if he said that the CDC was the “most corrupt federal agency in the history of the world.” 

Kennedy testified he didn’t say that exactly but did say “it’s the most corrupt agency at HHS and maybe the government.” 

Warnock concluded his five minutes of questions telling Kennedy that “it’s clear you’re carrying out your extremist beliefs” and that he represents “a threat to the public health of the American people.”

“For the first time, we’re seeing deaths from children from measles,” Warnock said. “We haven’t seen that in two decades. We’re seeing that under your watch. You are a hazard to the health of the American people.”

Lankford, Daines ask about medication abortion

Several senators, including Oklahoma Republican James Lankford and Montana Republican Steve Daines, asked Kennedy about the ongoing review of mifepristone, one of two prescription pharmaceuticals used in medication abortion. 

Kennedy said he spoke with FDA Commissioner Marty Makary about the topic just yesterday and committed to keeping senators informed, but didn’t appear to know much more than that. 

“I don’t know if they’re going to do an insurance claim study. That’s one way to do it. I don’t know exactly whether they’re doing epidemiological studies or observational studies. I don’t know exactly what they’re doing,” Kennedy said. “But I know I talked to Marty Makary about it yesterday, and he said those studies are progressing and that they’re ongoing. So I will keep your office informed at every stage.”

Kennedy testified that he didn’t know when exactly the studies would be completed. 

The FDA first approved mifepristone in 2000 before updating the prescribing guidelines in 2016 and during the coronavirus pandemic. 

It’s currently approved for up to 10 weeks gestation and can be prescribed via telehealth and shipped to patients. Mifepristone is the first pharmaceutical of medication abortion and is typically followed by misoprostol. 

Medication abortion accounted for about 64% of all abortions in 2023, according to research from the Guttmacher Institute. 

The Supreme Court rejected an effort to limit access to medication abortion last year in a case originally filed by four anti-abortion medical organizations and four anti-abortion doctors that were represented by Alliance Defending Freedom.

Justice Brett Kavanaugh wrote the opinion that “federal conscience laws have protected pro-life doctors ever since FDA approved mifepristone in 2000.”

Numerous medical organizations, including the American College of Obstetricians and Gynecologists and the American Medical Association, wrote briefs to the Supreme Court in that case attesting to the safety and efficacy of mifepristone. 

“The scientific evidence is overwhelming: major adverse events occur in less than 0.32% of patients,” the medical organizations wrote. “The risk of death is almost non-existent.”

Health and Human Services Secretary Robert F. Kennedy Jr. speaks alongside President Donald Trump at a news conference on May 12. (Andrew Harnik/Getty Images)

Public health and access to lifesaving vaccines are on the line in a high-stakes leadership battle at the Centers for Disease Control and Prevention.

Health and Human Services Secretary Robert F. Kennedy Jr.’s push to fire CDC director Susan Monarez is more than an administrative shake-up. The firing marks a major offensive by Kennedy to seize control of the agency and impose an anti-vaccine, anti-science agenda that will have profound effects on the lives and health of all Americans, public health leaders say.

Kennedy wants to see the Pfizer and Moderna messenger RNA-based covid-19 vaccines pulled from the market, according to two people familiar with the planning who asked not to be identified because they’re not authorized to speak to the press. He’s also set his sights on restricting or halting access to some pediatric immunizations, some public health leaders say.

His actions have already reduced federal help to states, creating the potential for more infectious disease outbreaks and incidences of foodborne illness. Some public health leaders say they expect Kennedy will use the CDC to publicize health information that isn’t grounded in science.

“It’s crazy season,” said Richard Besser, former acting CDC director during the Obama administration. “People want information they can trust to make critical decisions about their health. Until now, we’ve been able to say look at the CDC. Unfortunately, we’re not able to do that anymore.”

HHS spokesperson Emily Hilliard disputed the criticism.

“Secretary Kennedy remains firmly committed to delivering on President Trump’s promise to Make America Healthy Again, dismantling the failed status quo that fueled a nationwide chronic disease epidemic and eroded public trust in our public health institutions,” Hilliard said in a statement.

White House spokesperson Kush Desai said Kennedy and Commissioner of Food and Drugs Marty Makary have reiterated that covid shots will remain available for Americans who need and want them.

“The Trump administration is restoring Gold Standard Science as the sole guiding principle of health decision-making,” Desai said in an email. “Only the Fake News could ignore these facts to continue pushing Democrat talking points and hysteria.”

Behind the ouster

The shake-up began last week, when Kennedy sought to fire Monarez, a microbiologist who’d just been confirmed by the Senate in July. She refused to leave the position, and her lawyers said Kennedy sought to oust her because she wouldn’t fire senior staff or follow unscientific directives. Four top career officials at the CDC resigned on Aug. 27 in protest.

Career staffers at the CDC and some public health groups had hoped President Donald Trump would intervene and put the brakes on Kennedy. Instead, the White House backed Kennedy, saying Monarez was fired.

Trump on Sept. 1 demanded that drug companies show that covid vaccines work, in a further sign he’s not set on defending the shots.

“I hope OPERATION WARP SPEED was as ‘BRILLIANT’ as many say it was. If not, we all want to know about it, and why???” Trump said on Truth Social.

Operation Warp Speed was the initiative that Trump himself announced in 2020 to accelerate the development of covid vaccines, including the Pfizer and Moderna shots. The vaccines have proved safe and effective in multiple clinical trials; a study published in JAMA Health Forum estimated that they saved about 2.5 million lives worldwide.

CDC staffers are worried the agency’s next director won’t fight for science, according to an employee who asked not to be identified for fear of professional retaliation.

Trump’s support for Monarez’s ouster was a watershed moment that signaled there are no checks on Kennedy and his agenda, public health advocates say. Leading congressional Democrats such as Senate Minority Leader Chuck Schumer called for Kennedy’s firing. Hundreds of HHS staffers have also implored Congress to intervene, saying Kennedy threatens science and public health. He is slated to testify Sept. 4 before the Senate Finance Committee.

Kennedy said in a message to CDC staff that his focus is on boosting the agency’s reputation and leadership. The Atlanta-based agency was already reeling after the Trump administration pushed out thousands of its staff and a gunman who reportedly believed the covid vaccine had caused him health problems fired hundreds of rounds at its campus last month, killing a police officer.

“The CDC must once again be the world’s leader in communicable disease prevention. Together, we will restore trust,” Kennedy wrote. “Together, we will rebuild this institution into what it was always meant to be: a guardian of America’s health and security.” He said his deputy, Jim O’Neill, would serve as acting CDC director.

Nine former CDC directors or acting directors who served under both Republicans and Democrats criticized Kennedy in the aftermath of the Monarez firing, saying in an op-ed in The New York Times that the impact on public health is “unacceptable, and it should alarm every American, regardless of political leanings.”

HHS spokesperson Hilliard took exception with this point, listing four covid vaccines that continue to get the nod for use.

However, the Food and Drug Administration last

week approved updated covid mRNA boosters only for people 65 or older and others at high risk of complications. The CDC has also stopped recommending the shots for healthy children and pregnant women. Previously, the shots had been advised for anyone 6 months or older.

As a result, many people who don’t meet the criteria but want the vaccine will have to get prescriptions or consult with their doctors. Insurance may not always cover the shots, which can run around $200. Major drugstores such as Walgreens and CVS have said the shots may not be available at all pharmacies and may require a prescription.

The American Academy of Pediatrics on Aug. 19 broke with the administration, recommending that all young children get the covid vaccine. Insurance still may not cover the cost in some cases and parents could face obstacles in getting the vaccines without a prescription.

Next move: The advisory committee

Kennedy and his team changed official covid vaccine recommendations even though there have been no new safety issues. A dose of the 2023-24 covid mRNA vaccine prevented significant illness and death across all age groups, according to a study published in August led by a University of Michigan researcher. The virus killed about 1,000 people a week in the U.S. in mid-January, and cases are rising again and expected to accelerate this winter.

Kennedy has handpicked a vaccine advisory committee for the CDC that is reviewing mRNA-based covid vaccines, which he falsely claimed in 2021 were “the deadliest vaccine ever made.” The covid vaccine review is being led by Retsef Levi, a professor of operations management at the Massachusetts Institute of Technology who has said without evidence that the shots cause serious harm, including death. If the committee recommends against them, Kennedy and the FDA could then begin the process of removing them from the market.

Taking mRNA-based covid shots off the market would leave consumers with fewer options for protection. Paxlovid, an antiviral medication that treats the infection in high-risk adults, would be available.

The CDC advisory committee reviewing the covid shots is also probing a long-debunked link between aluminum, used in many childhood immunizations such as those for hepatitis A and pneumonia, and autism or allergies.

The group’s findings are expected to support the erroneous link, some public health officials say. HHS could then require drugmakers to undertake costly reformulations of the shots or stop manufacturing them altogether.

“That would set up the elimination of all childhood vaccines,” Besser said.

The advisory group’s next meeting is set for Sept. 18, although Sen. Bill Cassidy (R-La.) has called for the meeting to be indefinitely delayed. Cassidy, a physician who chairs the Senate Health, Education, Labor and Pensions Committee, voted for Kennedy’s confirmation as HHS secretary after receiving assurances, he said, that the longtime vaccine opponent wouldn’t disrupt the U.S. vaccination system. Kennedy’s promises, Cassidy said, included that he wouldn’t change the CDC’s Advisory Committee on Immunization Practices.

Kennedy removed all of the panel’s members in June and replaced them with his own appointees, including anti-vaccine activists.

Kennedy’s move to put his stamp on the CDC means states that have long relied on the agency’s expertise and help in crises such as disease outbreaks will largely be left to fend for themselves, said Ashish Jha, who served as President Joe Biden’s covid response coordinator from 2022 to 2023.

“States are going to be left on their own,” Jha said. “States will struggle with the CDC incapable and dysfunctional. Our system is not designed for states to go it alone.”

The CDC typically plays a critical role by assisting states with disease surveillance, public health interventions, and outbreak response, especially when a crisis spills across state lines. An outbreak of measles this year led to more than 1,400 cases nationwide, and states including Texas, where the outbreak was identified, struggled to get help from the CDC.

A CDC program that has long tracked pathogens in food has already reduced the number of hazards it looks for from eight to two, which public health leaders say is making it harder to identify outbreaks. Staff overseeing a CDC program that tracks outdoor pollution that can exacerbate asthma also have been cut.

The agency runs a hotline that doctors around the country can call to get treatment and other types of advice. Under Kennedy’s watch, the CDC has had to pare assistance because of staffing reductions, said Wendy Armstrong, vice president at the Infectious Diseases Society of America.

“Lives are 100% at stake, no question about it,” Armstrong said. “That you can no longer trust the recommendations out of the CDC is just devastating. It’s appalling to think we can’t trust that information is science-based anymore.”

Kennedy wants to shake up CDC leadership because he sees the agency as the heart of corruption and resistance within the federal health bureaucracy, according to people familiar with his planning. Kennedy has said the agency suffers from malaise and bias.

Many public health leaders, however, view the CDC as under siege by an administration they say is corrupting science for its own ends. HHS staffers signed onto a letter that now has more than 6,800 signatures, saying Kennedy is “endangering the nation’s health by repeatedly spreading inaccurate health information.”

Kennedy has also been fending off mounting criticism of his response to the shooting at the CDC’s headquarters. He responded to the attack on social media, hours later, after first posting pictures of himself fly-fishing.

Some younger staffers are considering leaving and some workers feel like the shooting accelerated Kennedy’s overhaul of the agency, the CDC employee said.

With the battle for control of the CDC still raging, public health leaders are now looking to Congress to put the brakes on Kennedy. Some Republican lawmakers have called for a review of Kennedy’s actions.

“These high profile departures will require oversight by the HELP Committee,” Cassidy said Aug. 27 on the social platform X. Cassidy had backed Monarez to lead the agency.

Renuka Rayasam, KFF Health News senior correspondent, and Andy Miller contributed to this article.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

Subscribe to KFF Health News’ free Morning Briefing.

This article first appeared on KFF Health News and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Susan Monarez, director of the Centers for Disease Control and Prevention, testifies during her confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions in the Dirksen Senate Office Building on June 25, 2025 in Washington, D.C.. (Photo by Kayla Bartkowski/Getty Images)

WASHINGTON — The director of the Centers for Disease Control and Prevention doesn’t appear inclined to leave her post, despite the Trump administration announcing Wednesday that she’s no longer running one of the country’s top public health agencies. 

Attorneys for Susan Monarez, who received Senate confirmation in late July, posted that she hasn’t been fired or resigned, but didn’t announce whether they plan to sue the administration. 

“When CDC Director Susan Monarez refused to rubber-stamp unscientific, reckless directives and fire dedicated health experts she chose protecting the public over serving a political agenda,” wrote Mark S. Zaid and Abbe David Lowell. “For that, she has been targeted. Dr. Monarez has neither resigned nor received notification from the White House that she has been fired, and as a person of integrity and devoted to science, she will not resign.”

The statement from Monarez’s attorneys came just hours after the Department of Health and Human Services, which oversees the CDC, wrote on social media that she was no longer running the agency. 

“Susan Monarez is no longer director of the Centers for Disease Control and Prevention,” the post stated. “We thank her for her dedicated service to the American people. @SecKennedy has full confidence in his team at@CDCgov who will continue to be vigilant in protecting Americans against infectious diseases at home and abroad.”

The Washington Post first reported the news. 

The U.S. Senate voted along party lines to confirm Monarez as CDC director in late July, giving her just weeks in one of the nation’s top public health roles.

Monarez’s last post on social media from her official account was on Aug. 22, marking the death of a police officer after a gunman opened fire at the CDC’s headquarters in Atlanta. 

“A large group of CDC employees and I attended today’s memorial for Officer David Rose, whose Tour of Duty ended on August 8 when he responded to shots fired,” Monarez wrote. “He leaves behind a legacy of love, courage, and service to the community that will never be forgotten.”

The dispute over Monarez’s position as CDC director appeared to potentially mark the beginning of a wave of resignations from other public health officials, including Director of the National Center for Immunization and Respiratory Diseases Demetre C. Daskalakis.

“I am unable to serve in an environment that treats CDC as a tool to generate policies and materials that do not reflect scientific reality and are designed to hurt rather than to improve the public’s health,” Daskalakis wrote in a lengthy social media post. “The recent change in the adult and children’s immunization schedule threaten the lives of the youngest Americans and pregnant people.”

Monarez second choice after Weldon

Monarez was President Donald Trump’s second choice for CDC director. He originally selected former Florida U.S. Rep. Dave Weldon to run the CDC shortly after he secured election to the Oval Office in November. But the White House pulled Weldon’s nomination in March, after it appeared he couldn’t secure the votes needed for confirmation.

Later that month, Trump announced his plans to nominate Monarez in a social media post.

“Dr. Monarez brings decades of experience championing Innovation, Transparency, and strong Public Health Systems,” Trump wrote. “She has a Ph.D. from the University of Wisconsin, and PostDoctoral training in Microbiology and Immunology at Stanford University School of Medicine.

“As an incredible mother and dedicated public servant, Dr. Monarez understands the importance of protecting our children, our communities, and our future. Americans have lost confidence in the CDC due to political bias and disastrous mismanagement. Dr. Monarez will work closely with our GREAT Secretary of Health and Human Services, Robert Kennedy Jr. Together, they will prioritize Accountability, High Standards, and Disease Prevention to finally address the Chronic Disease Epidemic and, MAKE AMERICA HEALTHY AGAIN!”

Restoring trust in CDC

Monarez testified in front of the U.S. Senate Committee on Health, Education, Labor and Pensions in June as part of her confirmation process. The committee voted 12-11 in July to send her nomination to the Senate floor, where Republicans approved her to the post later that month. 

Chairman Bill Cassidy, R-La., said during the committee’s markup that he believed Monarez would put science first and help to restore public trust in the agency. 

“The United States needs a CDC director who makes decisions rooted in science, a leader who will reform the agency and work to restore public trust in health institutions,” Cassidy said at the time. “With decades of proven experience as a public health official, Dr. Monarez is ready to take on this challenge.”

The James H. Shannon Building (Building One) on the NIH campus in Bethesda, Maryland. (Photo by Lydia Polimeni,/National Institutes of Health)

President Donald Trump’s freeze on $8 billion of congressionally appropriated funding to the National Institutes of Health was illegal, the Government Accountability Office reported Tuesday.

Orders Trump signed in the early days of his return to office and related administration directives violated the Impoundment Control Act by failing to spend money that Congress, which holds the power of the purse under the Constitution, had approved, the GAO report said.

Roughly 1,800 grants for health research were held up by the administration, the report said.

Trump’s Inauguration Day order ceased funding for a variety of health research grants that related to diversity, equity and inclusion, transgender issues or environmental harms. The Department of Health and Human Services issued a memo directing its agencies, including NIH, to cease publishing notices in the Federal Register of meetings of grant review boards.

GAO, an independent investigatory agency that reports to Congress, called those meetings “a key step in NIH’s grant review process.” HHS has since restarted notices of the meetings.

From February to June, the NIH released $8 billion less than it obligated in the past two years, representing a drop-off of more than one-third, according to the GAO. The gap between 2025 spending and that of previous years continued to grow, GAO said, with NIH obligating a lower amount of grant funding each month.

Illegal impoundment

The failure to fund grant awards violated the Impoundment Control Act and the Constitution, which certified Congress as the branch of government responsible for funding decisions, said GAO.

If a law is passed by Congress and signed by a president, it must be carried out by the executive branch, the watchdog said.

“The President must ‘faithfully execute’ the law as Congress enacts it,” the report said. “Once enacted, an appropriation is a law like any other, and the President must implement it by ensuring that appropriated funds are obligated and expended prudently during their period of availability unless and until Congress enacts another law providing otherwise. … The Constitution grants the President no unilateral authority to withhold funds from obligation.”

There are specific circumstances that allow for a funding freeze — a rescissions law, such as the one Congress passed last month to defund public broadcasters and foreign aid, is one example — but they did not apply to this case, the GAO said.

Delays may be permissible to allow a new presidential administration to ensure grants are awarded based on its priorities. But a complete block on funding is illegal, the GAO said. There is no evidence that other grant awards — or any other type of funding at HHS — took the place of the $8 billion in unspent grant money, the report said.

“While it can be argued that NIH reviewed grants to ensure that funds were spent in alignment with the priorities of the new administration, NIH did not simply delay the planned obligations of the funds,” the GAO said. “Rather, NIH eliminated obligations entirely by terminating grants it had already awarded.”

GAO can sue the executive branch based on its findings. The report noted there is already litigation from other parties over the frozen grants.

Dems call for reinstatement

Congressional Democrats responded to the report by harshly criticizing Trump and White House Office of Management and Budget Director Russ Vought and calling for the funds’ release.

“This is simple – Congress passed and the President signed into law investments in NIH research to help find cures and treatments for cancer, Alzheimer’s disease, ALS, diabetes, mental health issues, and maternal mortality,” U.S. House Appropriations Committee ranking Democrat Rosa DeLauro of Connecticut said in a statement. “But now, GAO has determined that President Trump and OMB Director Vought illegally withheld billions in funding for research on diseases affecting millions of American families—research that brings hope to countless people suffering.”

Senate Appropriations Vice Chair Patty Murray, a Washington state Democrat, said in a statement the funding freeze “dangerously set back” efforts to cure cancer, Alzheimer’s and other diseases.

“Today’s decision affirms what we’ve known for months: President Trump is illegally blocking funding for medical research and shredding the hopes of patients across the country who are counting on NIH-backed research to propel new treatments and cures that could save their lives,” Murray said. “It is critical President Trump reverse course, stop decimating the NIH, and get every last bit of this funding out.”

An HHS spokesperson deferred a request for comment Tuesday to OMB.

An agency investigated by the GAO is generally given a draft of the watchdog’s findings and asked to respond.

The HHS response, obtained by States Newsroom, said grant reviews were back on schedule, though it did not address grant obligations.

“Despite the short delay in scheduling and holding peer review and advisory council meetings to allow for the administration transition, NIH has been on pace with its reviewing grant applications and holding meetings and has caught up from the pause when compared to prior years,” the response said.

GAO’s summary of the HHS response said the department had restarted meetings of grant review boards and provided some “factual information” but did not justify the lack of grant spending or provide current status of payments for previously approved grants. 

Nasal Narcan, used to reverse an overdose, stock the inside of Milwaukee County's first harm reduction vending machine. (Photo | Isiah Holmes)

Milwaukee County Executive David Crowley is proposing to utilize over $9 million in opioid settlement funds to support seven initiatives aimed at expanding treatment and reducing opioid use disorder. Crowley said in a statement that his administration “continues to deploy opioid settlement dollars across Milwaukee County.” 

“These upstream investments are proving to be effective,” Crowley said, “but we know there’s more work to do in expanding substance use prevention, harm reduction, treatment, and recovery efforts.” 

The Milwaukee County Board Committee on Finance unanimously approved Crowley’s proposal during a meeting Thursday. Next week, the full county board will vote on whether to approve the plan. The projects, proposed for the 2026-28 fiscal years, include providing outreach to older adults with disabilities through door-to-door canvasing and  funding community-based organizations which partner with the Department of Health and Human Services (DHHS). Providing more staffing to the medical examiner’s office, funding residential room and board programs for people struggling with addiction and enhancing the county’s publicly available data analysis of the overdose crisis are among the other proposed initiatives. 

“Through these proven initiatives and by working together, we will keep leading the way to change the lives of individuals affected by substance use disorder and reduce the likelihood of overdose-related fatalities in our community — because lives depend on it,” Crowley said in a statement. 

Shakita LaGrant-McClain, executive director of DHHS, said the funding will allow the department to “continue the life-saving work that began with the initial round of opioid settlement funds…We are seeing promising trends and look forward to continuing our prevention, harm reduction, treatment and recovery work, including ensuring residents have access to harm reduction supplies, targeted community outreach, and collaboration with community partners.”

A publicly available dashboard illustrates the toll the overdose epidemic has taken on Milwaukee County. It provides information on both fatal and non-fatal overdoses, which communities are most impacted, how much anti-overdose Naloxone has been utilized, and more. Across Milwaukee County, over 4,500 people have lost their lives to an overdose between 2016 and 2024. The deaths peaked in 2022, which saw 674 people lose their lives to an overdose. Non-fatal overdoses are even more common; more than 5,400 occurred during 2022. There have been 1,061 non-fatal overdoses so far this year and 124 people have died of an overdose in 2025. 

The data shows that so far this year, 14% of fatal overdoses have been people between 55-59 years old and 11% were  60-64. People aged 35-39 made up 13% of the fatal overdoses this year. The lowest percentages came from young people 15-29 years old, and much older people aged 75-85 years or more. 

Over 18 years, Milwaukee County will receive a total of $111 million in opioid settlement funds. So far, $34 million has been allocated across three cohorts of funded projects focused on breaking cycles of addiction, advancing racial equality and improving community health.

GET THE MORNING HEADLINES.

SUBSCRIBE

Reading Time: 4 minutes

The Social Development Commission, or SDC, is asking the federal government to reverse a decision made by the state that could alter the anti-poverty agency’s funding options. 

Here’s what we know.

The community action decision 

The Wisconsin Department of Children and Families decided in May to remove the SDC’s community action agency status, effective July 3.

Although the department believes SDC has not been operating anti-poverty services since it shut down in April 2024, despite reopening in December, SDC’s leaders have said the state did not follow the proper process to make this decision.

Without this designation, SDC will not be eligible for a Community Services Block Grant, which is a small portion of its budget but significant to its efforts to pay back employees and rebuild its service programs.

How does a federal review work? 

When a state decides to rescind community action status or the related block grant funding from a local agency, the agency can request a review from the U.S. Department of Health and Human Services within 30 days. 

SDC submitted a request for a review of the state’s community action decision to the department on June 9, citing concerns about due process. 

The Department of Health and Human Services, or HHS, will evaluate if the state’s determination process followed the guidance on the termination or reduction of funding for entities eligible for the Community Services Block Grant, according to a spokesperson from the department. 

The Division of Community Assistance, which is part of the Office of Community Services within the federal department, oversees block grant funding for community action agencies. 

“I think that HHS is concerned about the process that was used to de-designate SDC, and so my expectation is that they will be talking to the state about the process,” said William Sulton, SDC’s attorney.

The Department of Children and Families received notification on June 11 from the Office of Community Services that SDC requested a review, but did not receive the request itself, according to Gina Paige, communications director for the department.

The review will be completed within 90 days of receiving all required documentation from the state, according to federal law. If not completed in the 90-day time frame, the state’s decision will be upheld. 

As part of the request, SDC is asking the Department of Health and Human Services for direct financial assistance. 

According to the CSBG Act, if a state violates the de-designation process –  by terminating or reducing funding of an eligible entity before the state hearing and the secretary’s review – the Health and Human Services secretary is authorized to provide financial assistance to the entity affected until the violation is corrected.

SDC’s concerns 

SDC raised two main concerns with the state’s determination process in the request, based on state and federal laws.  

The first concern is that the public hearing on SDC’s community action status, held by the Department of Children and Families on April 4, did not meet the legal requirements of a “hearing on the record.”

“You’re supposed to be permitted to call witnesses and present evidence,” Sulton said. “… We were given seven minutes to make a speech, and that was it.” 

SDC also says that both the Department of Children and Families’ secretary and the legislative bodies of the city of Milwaukee and Milwaukee County would have to sign off on the decision, based on a state statute that requires the legislative body that initially granted the agency community action status to approve rescinding it. 

“They didn’t go out and get position statements from the city and the county’s legislative bodies,” Sulton said. 

The department did not comment on these claims. (Paige previously said it has worked closely with the Office of Community Services and Milwaukee County to determine the process needed to move forward with de-designating SDC.)

Although Milwaukee County’s Office of Corporation Counsel submitted a letter to say it found no records of the Board of Supervisors taking action on SDC’s status as a community action agency, Sulton said that doesn’t mean there are no records. 

He argues that this provision of the law, added in 1983, was put in place to protect SDC from arbitrary state action.

Funding deadline

In May, three state lawmakers asked SDC to consider voluntarily de-designating, which would allow the state and Milwaukee County to more quickly find an interim service provider to use SDC’s allocated funds in Milwaukee County. 

The $1.18 million in 2024 block grant funding could be recouped by the federal government if not spent by Sept. 30, 2025, according to the Department of Children and Families. 

However, Sulton said when he reached out to the Department of Health and Human Services before filing the review, an employee told him the 2024 funds had to be obligated by 2026.

“To the extent that anybody has the impression that this money has to be obligated by September or it’ll be lost, HHS says it’s not the case,” he said. 

States and subrecipients usually have two years to distribute funds, but it depends on state-specific policies, according to HHS.

The state’s Sept. 30 deadline marks two years after the beginning of the 2024 fiscal year in October 2023, according to Paige. 

Though Paige said that SDC’s request for review is perpetuating the lack of services in Milwaukee County, she added that the department plans to seek a six-month liquidation extension from the federal government.

“It’s quite possible that we’re gonna be on a really tight timeline to get that money out the door, so that’s why we’re hoping that we can work with the federal government and see if they can allow us an extension to expend it a little bit longer,” Paige said. 

Board member changes

The SDC board added two commissioners in May – Milwaukee Public Schools appointed Michael Harris, and the Interfaith Conference of Greater Milwaukee appointed Peter Fetzer, an attorney at Foley & Lardner LLP. 

In the last seven months, the SDC board has expanded from three to 10 commissioners, thanks to several appointments to vacant seats. The board is designed to have 18 members at full capacity. 

Commissioner Lucero Ayala’s term has ended, according to Sulton. Ayala was nominated and selected last year to fill the remainder of Serina Chavez’s term as an elected commissioner.

Milwaukee Social Development Commission wants feds to reverse state funding decision   is a post from Wisconsin Watch, a non-profit investigative news site covering Wisconsin since 2009. Please consider making a contribution to support our journalism.